Cargando…
Glaucoma, Stem Cells, and Gene Therapy: Where Are We Now?
Glaucoma is the second most common cause of blindness, affecting 70~80 million people around the world. The death of retinal ganglion cells (RGCs) is the main cause of blindness related to this disease. Current therapies do not provide enough protection and regeneration of RGCs. A novel opportunity...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Stem Cell Research
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741193/ https://www.ncbi.nlm.nih.gov/pubmed/28844129 http://dx.doi.org/10.15283/ijsc17029 |